Simpson Thacher Represents C. R. Bard, Inc. in $750 Million Accelerated Share Repurchase
12.22.10
This is only gets display when printing
The Firm represented C. R. Bard, Inc. (the “Company”) in its entry into an accelerated share repurchase transaction with Goldman, Sachs & Co. to repurchase in the aggregate approximately $750 million of the Company’s common stock.
C. R. Bard, Inc. is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.
The Simpson Thacher team for the transactions included Joyce Xu, Alina Casner and Sunny Cheong (Derivatives). A.J. Kess and Stephan Feder (Capital Markets) also provided valuable advice.